Secondary Malignancies

Articles

Rethinking Soy

Dr. Susan Love Research Foundation blog.dslrf.org/?p=129. 12/8/2009

Risk of new Primary Non Breast Cancers After Breast Cancer Treatment: A Dutch Population-Based Study

Journal of Clinical Oncology, Vol 26, #8, pp.1239-1246

Long-Term Complications following Conservative Surgery and Radiation Therapy in Patients with Early Stage Breast Cancer

International Journal of Radiation Oncology,  Biology, and Physics, Volume 23, # 5, 1992, pp. 915-923.  First author: Pierce, SM

Cardiovascular Death and Second Non-Breast Cancer Malignancy after Postmastectomy Radiation and Doxorubicin Based Chemotherapy

International Journal of Radiation Biology Physics, Vol. 57, # 2, 2003, pp. 327-335.  First author: Woodward, W.A.

Second Malignancies After Treatment of Early-Stage Breast Cancer: Lumpectomy and Radiation Vs. Mastectomy

Journal of Clinical Oncology, Vol. 18, # 12, June , 2000, pp. 2406-2412. First author: Obedian, E.

Online Tool to Guide Decisions in BRCA 1/2 Mutation Carriers

Secondary Hematologic Malignancies after Breast Cancer Chemotherapy

Leukemia, Lymphoma, Vol. 46, # 5, 2005, pp. 1183-1188.  First author: Park, M.

Acute Myeloid Leukemia After Breast Cancer: a Population-Based Comparison with Hematologic Malignancies and Other Cancers

Annals of Oncology, Volume 20, # 1, 2009, pp. 103-9.  Beadle, G.

Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women with Estrogen Receptor-Positive Ductal Carcinoma in Situ: A Study Based on NSABP B-24

Journal of Clinical Oncology, Vol. 30, # 12, April 20, 2012, pp. 1268-1273.  First author:  Allred, D. Craig

Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Trials of Adjuvant Epirubicin for Early Breast Cancer: Correlation with doses of Epirubicin and Cyclophosphamide

Journal of Clinical Oncology, Volume 23, # 18, June 20, 2005, pp. 4179-4191.  First author: Praga, Claudia.

Administration of Chemotherapy has No Effect on the Low Rate of AML/MDS: A Retrospective Study

ASCO Breast Cancer Symposium, September 13-15, San Francisco, presentation highlights, presented by Neelima Denduluri, MD, Abstract # 62

Second Malignant Neoplasms: Assessment and Strategies for Risk Reduction

The Journal of Clinical Oncology, Volume 30, # 30, October 20, 2012, pp. 3734-3745.  First author:  Wood, Marie E.